U.S. researchers say depression may be an early symptom of Parkinson's disease.
A new study to be presented at the American Academy of Neurology's 59th Annual Meeting -- which begins next week in Boston -- found that people who are taking anti-depressant medications are more likely to develop Parkinson's disease than people who are not taking the medications.
Researchers said that in the year before their Parkinson's disease was diagnosed, people who were taking anti-depressants were nearly twice as likely to develop Parkinson's disease as those who were not taking anti-depressants, the Harvard School of Public Health said in a release.
The study said the relationship was only apparent in the year before the onset of the disease.
Copyright 2007 by United Press International
Related stories:
Why dopamine freezes parkinson patients and drives drug addicts
Parkinson's disease and drug addiction are polar opposite diseases, but both depend upon dopamine in the brain. Parkinson's patients don't have enough of it; drug addicts get too much of it. Although the importance of dopamine in these disorders has been well known, the way it works has been a mystery.
NVIDIA Announced New Geforce GTX 200 GPUs
Imagine instead of taking over five hours to convert a video for your iPod, it only takes 35 minutes. Imagine using your PC to simulate protein folding to help find a cure for debilitating diseases. Imagine that your PC can dramatically accelerate everyday tasks, and deliver an exciting visual experience in the process.
Occupational Therapists Use Wii for Parkinson's Study
It’s Ingrid Bell’s turn at bat. She steps up to the plate, awaiting the pitch. A 70-mph fastball soars toward her. She swings and connects with the ball. Foul ball! Everyone cheers for her anyway.
Pieces coming together in Parkinson's, cholesterol puzzle
In 2006, University of North Carolina at Chapel Hill researchers published a study that found people with low levels of LDL cholesterol are more likely to have Parkinson's disease than people with high LDL levels.
US stands to lose a generation of young researchers
Five consecutive years of flat funding the budget of the National Institutes of Health (NIH) is deterring promising young researchers and threatening the future of Americans’ health, a group of seven preeminent academic research institutions warned today.
High blood pressure pill cuts risk of Parkinson's disease
People taking a widely used group of drugs known as calcium channel blockers to treat high blood pressure also appear to be cutting their risk of Parkinson’s disease, according to a study published in the February 6, 2008, online issue of
Neurology.
Stem cell research aims to tackle Parkinson's disease
Scientists in Sweden are developing new ways to grow brain cells in the laboratory that could one day be used to treat patients with Parkinson’s disease, an international conference of biologists organised by the European Science Foundation (ESF) was told last week.
Sleep chemical central to effectiveness of deep brain stimulation
A brain chemical that makes us sleepy also appears to play a central role in the success of deep brain stimulation to ease symptoms in patients with Parkinson’s disease and other brain disorders. The surprising finding is outlined in a paper published online Dec. 23 in
Nature Medicine.